These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 30256919)
41. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis. Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187 [TBL] [Abstract][Full Text] [Related]
42. A comparison of interferon-γ and IP-10 for the diagnosis of tuberculosis. Holm LL; Rose MV; Kimaro G; Bygbjerg IC; Mfinanga SG; Ravn P; Ruhwald M Pediatrics; 2014 Dec; 134(6):e1568-75. PubMed ID: 25422019 [TBL] [Abstract][Full Text] [Related]
43. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease. La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810 [TBL] [Abstract][Full Text] [Related]
44. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT]. Matsumoto T; Yamazaki T Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946 [TBL] [Abstract][Full Text] [Related]
45. Alternative Quantiferon cytokines for diagnosis of children with active tuberculosis and HIV co-infection in Ghana. Lundtoft C; Awuah AA; Nausch N; Enimil A; Mayatepek E; Owusu-Dabo E; Jacobsen M Med Microbiol Immunol; 2017 Jun; 206(3):259-265. PubMed ID: 28299430 [TBL] [Abstract][Full Text] [Related]
46. Role of QuantiFERON-TB-Gold In Tube assay for active and latent tuberculosis infection in investigation of tuberculosis outbreak in a university. Li CY; Chen HC; Cheng HY; Chian CF; Chang FY; Chen HI; Ku CH; Lin JC J Microbiol Immunol Infect; 2015 Jun; 48(3):263-8. PubMed ID: 24184001 [TBL] [Abstract][Full Text] [Related]
47. Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection. Hoff ST; Peter JG; Theron G; Pascoe M; Tingskov PN; Aggerbeck H; Kolbus D; Ruhwald M; Andersen P; Dheda K Eur Respir J; 2016 Mar; 47(3):919-28. PubMed ID: 26677940 [TBL] [Abstract][Full Text] [Related]
48. Identification of false-positive QuantiFERON-TB Gold In-Tube assays by repeat testing in HIV-infected patients at low risk for tuberculosis. Gray J; Reves R; Johnson S; Belknap R Clin Infect Dis; 2012 Feb; 54(3):e20-3. PubMed ID: 22057704 [TBL] [Abstract][Full Text] [Related]
49. The diagnostic accuracy of Th1 (IFN-γ, TNF-α, and IL-2) and Th2 (IL-4, IL-6 and IL-10) cytokines response in AFB microscopy smear negative PTB- HIV co-infected patients. Kisuya J; Chemtai A; Raballah E; Keter A; Ouma C Sci Rep; 2019 Feb; 9(1):2966. PubMed ID: 30814543 [TBL] [Abstract][Full Text] [Related]
50. Immunologic Biomarkers in Peripheral Blood of Persons With Tuberculosis and Advanced HIV. Queiroz ATL; Araújo-Pereira M; Barreto-Duarte B; Gomes-Silva A; Costa AG; Andrade AMS; Miguez-Pinto JP; Spener-Gomes R; Souza AB; Benjamin A; Sant'Anna F; Figueiredo MC; Mave V; Salgame P; Ellner JJ; Sterling TR; Cordeiro-Dos-Santos M; Andrade BB; Rolla VC Front Immunol; 2022; 13():890003. PubMed ID: 35757685 [TBL] [Abstract][Full Text] [Related]
51. C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. Tenforde MW; Gupte N; Dowdy DW; Asmuth DM; Balagopal A; Pollard RB; Sugandhavesa P; Lama JR; Pillay S; Cardoso SW; Pawar J; Santos B; Riviere C; Mwelase N; Kanyama C; Kumwenda J; Hakim JG; Kumarasamy N; Bollinger R; Semba RD; Campbell TB; Gupta A; PLoS One; 2015; 10(2):e0117424. PubMed ID: 25719208 [TBL] [Abstract][Full Text] [Related]
52. Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis. Chegou NN; Sutherland JS; Namuganga AR; Corstjens PL; Geluk A; Gebremichael G; Mendy J; Malherbe S; Stanley K; van der Spuy GD; Kriel M; Loxton AG; Kriel B; Simukonda F; Bekele Y; Sheehama JA; Nelongo J; van der Vyver M; Gebrexabher A; Hailu H; Esterhuyse MM; Rosenkrands I; Aagard C; Kidd M; Kassa D; Mihret A; Howe R; Cliff JM; Crampin AC; Mayanja-Kizza H; Kaufmann SHE; Dockrell HM; Ottenhoff THM; Walzl G; Sci Rep; 2018 Feb; 8(1):2675. PubMed ID: 29422548 [TBL] [Abstract][Full Text] [Related]
53. Accuracy of the interferon-γ release assay for the diagnosis of active tuberculosis among HIV-seropositive individuals: a systematic review and meta-analysis. Huo ZY; Peng L BMC Infect Dis; 2016 Jul; 16():350. PubMed ID: 27450543 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of a new tuberculosis-related interferon gamma release assay for tuberculosis infection diagnosis in Huzhou, eastern China. Qian F; Wang W; Qiu Z; Shen Y; He J; Li D; Zhong J; Dai L Indian J Pathol Microbiol; 2013; 56(2):125-8. PubMed ID: 24056648 [TBL] [Abstract][Full Text] [Related]
55. Latent Tuberculosis screening using interferon-gamma release assays in an Australian HIV-infected cohort: is routine testing worthwhile? Doyle JS; Bissessor M; Denholm JT; Ryan N; Fairley CK; Leslie DE J Acquir Immune Defic Syndr; 2014 May; 66(1):48-54. PubMed ID: 24457631 [TBL] [Abstract][Full Text] [Related]
56. Parallel measurement of IFN-γ and IP-10 in QuantiFERON®-TB Gold (QFT) plasma improves the detection of Mycobacterium bovis infection in African buffaloes (Syncerus caffer). Bernitz N; Kerr TJ; Goosen WJ; Clarke C; Higgitt R; Roos EO; Cooper DV; Warren RM; van Helden PD; Parsons SDC; Miller MA Prev Vet Med; 2019 Aug; 169():104700. PubMed ID: 31311648 [TBL] [Abstract][Full Text] [Related]
57. Host Protein Biomarkers Identify Active Tuberculosis in HIV Uninfected and Co-infected Individuals. Achkar JM; Cortes L; Croteau P; Yanofsky C; Mentinova M; Rajotte I; Schirm M; Zhou Y; Junqueira-Kipnis AP; Kasprowicz VO; Larsen M; Allard R; Hunter J; Paramithiotis E EBioMedicine; 2015 Sep; 2(9):1160-8. PubMed ID: 26501113 [TBL] [Abstract][Full Text] [Related]
58. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. Dyrhol-Riise AM; Gran G; Wentzel-Larsen T; Blomberg B; Haanshuus CG; Mørkve O BMC Infect Dis; 2010 Mar; 10():57. PubMed ID: 20210999 [TBL] [Abstract][Full Text] [Related]
59. [The clinical application of quantiferon TB-2G: its usefulness and limitations]. Sato S; Nagai H Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654 [TBL] [Abstract][Full Text] [Related]
60. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. Goletti D; Raja A; Ahamed Kabeer BS; Rodrigues C; Sodha A; Butera O; Carrara S; Vernet G; Longuet C; Ippolito G; Thangaraj S; Leportier M; Girardi E; Lagrange PH J Infect; 2010 Jul; 61(2):133-43. PubMed ID: 20470822 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]